NCT05638204 Effectiveness of the Suicidal Crisis Intervention (SCI)
| NCT ID | NCT05638204 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Ghent |
| Condition | Suicide |
| Study Type | INTERVENTIONAL |
| Enrollment | 390 participants |
| Start Date | 2023-07-11 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 390 participants in total. It began in 2023-07-11 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The main objective of this project is to be able to offer a new, specific evidence-based short-term treatment method, the Suicidal Crisis Intervention (SCI), to reduce suicidality. In addition, this study aims to investigate the influence of SCI on other important aspects of suicidality (secondary goal) such as hopelessness, defeat, entrapment, and interpersonal needs.
Eligibility Criteria
Inclusion Criteria Patient: * After a suicide attempt or suicidal crisis * ≥ 18 years * Availability of a smartphone, tablet and/or computer with internet access, * Dutch-speaking. Exclusion Criteria Patient: * Limited comprehension, cognitive impairment * Psychotic disorder * Unsuitable for individual therapy * Receiving other forms of care is not an exclusion criterion. Inclusion Criteria Close one: * close one of the patient * ≥ 18 years * Dutch- speaking
Contact & Investigator
Gwendolyn Portzky, Phd
PRINCIPAL INVESTIGATOR
University Ghent
Frequently Asked Questions
Who can join the NCT05638204 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Suicide. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05638204 currently recruiting?
Yes, NCT05638204 is actively recruiting participants. Contact the research team at eva.dejaegere@ugent.be for enrollment information.
Where is the NCT05638204 trial being conducted?
This trial is being conducted at Beernem, Belgium, Bilzen, Belgium, Boechout, Belgium, Geel, Belgium and 8 additional locations.
Who is sponsoring the NCT05638204 clinical trial?
NCT05638204 is sponsored by University Hospital, Ghent. The principal investigator is Gwendolyn Portzky, Phd at University Ghent. The trial plans to enroll 390 participants.